ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0J2O Halozyme Therapeutics Inc

18.26
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 146.69M316.61M151.86M195.99M267.59M443.31M660.12M829.25M
Operating Income -83.21M81M-69.33M-67.61M144.26M275.9M267.53M337.57M
Pre Tax Income -101.86M61.61M-79.79M-72.25M129.3M248.52M248.92M348.33M
Net Income -103.02M62.97M-80.33M-72.24M129.09M402.71M202.13M281.59M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.7480.417-0.525-0.4990.9012.7641.412.007
EBIT -83.21M81M-61.75M-60.62M149.68M254.94M264.82M337.57M
EBITDA -80.8M83.16M-66.94M-63.54M147.54M278.9M317.17M422.43M

Your Recent History

Delayed Upgrade Clock